• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ikena Oncology, Inc. - Common Stock (NQ:IKNA)

1.240 -0.030 (-2.36%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,285,110
Open 1.270
Bid (Size) 1.240 (4)
Ask (Size) 1.280 (69)
Prev. Close 1.270
Today's Range 1.200 - 1.280
52wk Range 0.9707 - 1.940
Shares Outstanding 36,269,993
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
On Thursday, there are stocks with unusual volume. Let's take a look.
July 17, 2025
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 15, 2025
Via Benzinga

Performance

YTD
-24.8%
-24.8%
1 Month
-7.5%
-7.5%
3 Month
+4.2%
+4.2%
6 Month
-18.4%
-18.4%
1 Year
-26.0%
-26.0%

More News

Read More
Tuesday's after hours session: top gainers and losers
July 15, 2025
Via Chartmill
Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals
July 15, 2025
From Ikena Oncology, Inc.
Via GlobeNewswire
The Analyst Landscape: 4 Takes On Ikena Oncology
March 19, 2024
Via Benzinga
Ikena Oncology: Q4 Earnings Insights
March 12, 2024
Via Benzinga
Ikena Oncology Announces ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Merger with Inmagene Biopharmaceuticals
July 11, 2025
From Ikena Oncology, Inc.
Via GlobeNewswire
Traws Pharma Announces Management Updates
March 28, 2025
From Traws Pharma, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 23, 2024
Via Benzinga
Ikena Oncology and Inmagene Biopharmaceuticals Announce Agreement for Merger and Private Placement
December 23, 2024
From Ikena Oncology, Inc.
Via GlobeNewswire
Ikena Oncology Reports Third Quarter 2024 Financial Results
November 07, 2024
From Ikena Oncology, Inc.
Via GlobeNewswire
IKNA Stock Earnings: Ikena Oncology Beats EPS for Q2 2024
August 09, 2024
Via InvestorPlace
Ikena Oncology Reports Second Quarter 2024 Financial Results
August 08, 2024
From Ikena Oncology, Inc.
Via GlobeNewswire
Ikena Oncology Discontinues IK-930 Program And Cuts Workforce, Analyst Calls It 'Disappointing'
May 29, 2024
Via Benzinga
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 29, 2024
Via Benzinga
This American Airlines Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
May 29, 2024
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 29, 2024
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 29, 2024
Via InvestorPlace
UPDATE – Ikena Oncology Announces Strategic Update
May 28, 2024
From Ikena Oncology, Inc.
Via GlobeNewswire
Ikena Oncology Announces Strategic Update
May 28, 2024
From Ikena Oncology, Inc.
Via GlobeNewswire
IKNA Stock Earnings: Ikena Oncology Beats EPS for Q1 2024
May 13, 2024
Via InvestorPlace
Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update
May 13, 2024
From Ikena Oncology, Inc.
Via GlobeNewswire
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum
April 10, 2024
From Ikena Oncology, Inc.
Via GlobeNewswire
Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results
March 12, 2024
From Ikena Oncology, Inc.
Via GlobeNewswire
Ikena Oncology to Participate in TD Cowen 44th Annual Health Care Conference
February 27, 2024
From Ikena Oncology, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Ikena Oncology, Inc. - Common Stock publicly traded?
Yes, Ikena Oncology, Inc. - Common Stock is publicly traded.
What exchange does Ikena Oncology, Inc. - Common Stock trade on?
Ikena Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ikena Oncology, Inc. - Common Stock?
The ticker symbol for Ikena Oncology, Inc. - Common Stock is IKNA on the Nasdaq Stock Market
What is the current price of Ikena Oncology, Inc. - Common Stock?
The current price of Ikena Oncology, Inc. - Common Stock is 1.240
When was Ikena Oncology, Inc. - Common Stock last traded?
The last trade of Ikena Oncology, Inc. - Common Stock was at 07/22/25 04:00 PM ET
What is the market capitalization of Ikena Oncology, Inc. - Common Stock?
The market capitalization of Ikena Oncology, Inc. - Common Stock is 44.97M
How many shares of Ikena Oncology, Inc. - Common Stock are outstanding?
Ikena Oncology, Inc. - Common Stock has 45M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap